Technology

Artificial Intelligence Big Data Cloud Computing Cyber Security Data Management Electronics Enterprise & Network Technology Financial Technology Hardware Mobile & Wireless Nanotechnology Semiconductor Software Telecommunications
News Release Digital Asset Direct

PathAI will Present on Analytical and Clinical Validation of AI-based NASH Clinical Trial Digital Pathology Tool at EASL 2023, and Announces Launch of NASH Explore Product

PathAI

PathAI, a leading provider of AI-powered pathology, will give a late-breaker presentation on new results from analytical and clinical validation studies that tested their AIM-NASH TM product and workflow’s accuracy, repeatability, reproducibility, and clinical validity across thousands of samples from several clinical trials, at the European Association for the Study of the Liver’s International Liver Congress 2023 (EASL), which will be held in Vienna, Austria from June 21 to 24, 2023. During EASL, PathAI will also formally launch and release details on its new NASH Explore TM product. P athAI’s analytical and clinical validation studies demonstrated that AIM-NASH-assisted pathologist reads of NASH resolution, hepatocellular ballooning, and lobular inflammation were superior to unaided pathologist assessment. Notably, there was a large improvement in scoring accuracy for ballooning and lobular inflammation, which are two of the most challenging components to score and standardize across pathologist reads. These results support PathAI’s vision to develop AI-powered digital pathology solutions to assist pathologists in achieving accurate and reproducible scoring, and complement prior results showing that AI-powered digital pathology is sensitive to drug effect that is not detected by categorical pathologist scoring 1 2, while also having the potential to control placebo response rates in NASH clinical trials 3. “The results from these studies inspire confidence in the robustness and value of AIM-NASH, and will pave the way to ultimately adopting AI-assisted NASH scoring as our new gold standard to ensure the greatest confidence in measuring true drug effect in NASH clinical trials,” said Stephen Harrison, M.D., chairman of Summit Clinical Research and a pioneer in the field of liver research and lead author on the study. At EASL, PathAI is also unveiling NASH Explore, an AI-derived panel of >500 histopathology features that spatially characterize NASH biopsy tissue microarchitecture at the cellular-level from H&E whole-slide images. It characterizes the H&E liver biopsy microenvironment at unprecedented resolution, giving drug developers and clinical researchers the ability to unlock insights that will enable precision drug development in non-alcoholic steatohepatitis (NASH). “Manual ordinal histologic scoring of fat, inflammation, ballooning and fibrosis from liver biopsies has been the gold standard in NASH assessment for enrollment and therapeutic efficacy, but the NASH community has been pushing for more,” said Andy Beck, M.D., Ph.D., chief executive officer and co-founder of PathAI. “NASH Explore will help uncover new histologic signatures and biomarkers of therapeutic response that could be even more predictive of patient outcomes, and provide more precision in stratifying patients for targeted therapies.” In response to the NASH community’s request for more sensitive measures of fibrosis that can be seamlessly integrated into existing clinical trial workflows, NASH Explore was developed to not only infer the presence of fibrosis in whole slide images of H&E-stained tissue sections, but also 1) categorize fibrosis into clinically relevant subtypes, and 2) quantify the presence of these fibrosis subtypes in liver lobular zones. By enabling sensitive, specific fibrosis detection from whole slide images (i.e., without requiring proprietary scanning of physical glass slides), NASH Explore allows for rapid and scalable interrogation into patterns of fibrosis that reflect true disease progression and regression. NASH Explore complements PathAI’s current AIM-NASH product, an AI-powered digital pathology tool that assists pathologists in performing NASH CRN scoring. PathAI’s poster and oral presentation schedule at EASL: Characterizing the histologic implications of resmetirom-induced liver volume reduction using artificial intelligence-powered digital pathology (Abstract OS-029) In partnership with Madrigal Pharmaceuticals 21 June, 9:00-18:00 CEST Analytical and clinical validation of AIM-NASH: a digital pathology tool for artificial intelligence-based measurement of nonalcoholic steatohepatitis histology (Abstract 4102) Oral presentation by: Stephen Harrison, MD, FAASLD 22 June, 18:15-18:30 CEST For more information, visit booth F4 at EASL for a live demo of NASHExplore, or contact us at NASH@pathai.com. Additional information can be found at www.NASHExplore.com. Footnotes 1. https://pubmed.ncbi.nlm.nih.gov/33570776/ 2. https://www.pathai.com/resources/comparison-of-manual-vs-machine-learning-approaches-to-liver-biopsy-scoring-for-nash-and-fibrosis-a-post-hoc-analysis-of-the-falcon-1-study/ 3. https://www.pathai.com/resources/comparison-of-the-effects-of-semaglutide-on-liver-histology-in-patients-with-non-alcoholic-steatohepatitis-cirrhosis-between-machine-learning-model-assessment-and-pathologist-evaluation/ About PathAI PathAI is the only AI-focused technology company to provide comprehensive precision pathology solutions from wet lab services to algorithm deployment for clinical trials and diagnostic use. Rigorously trained and validated with data from more than 15 million annotations, its AI-powered models can be leveraged to optimize the analysis of patient samples to improve efficiency and accuracy of pathology interpretation, as well as to better gauge therapeutic efficacy and accelerate drug development for complex diseases. PathAI, which is headquartered in Boston, MA, and operates a CAP/CLIA-certified laboratory in Memphis, TN, is proud to have a team of 600+ innovative thinkers from around the globe. For more information, please visit www.pathai.com. Contact Details Maggie Naples SVM Public Relations and Marketing Communications +1 401-490-9700 pathai@svmpr.com Company Website https://www.pathai.com/

June 21, 2023 10:00 AM Eastern Daylight Time

Inflectra Unveils Rapise v8.0: Revolutionizing Test Automation Frameworks

Inflectra

Inflectra, a leading provider of enterprise software that helps companies deliver faster, increase quality and reduce risk, proudly announced the latest release of its Rapise v8.0, its state-of-the-art test automation platform. Designed to accommodate diverse applications, including web, mobile, desktop, and APIs, Rapise simplifies and enhances the testing process. It boasts extensive compatibility with various business applications such as Salesforce, ServiceNow, Oracle Fusion, and Microsoft Dynamics, enabling comprehensive testing across multiple technologies. With Rapise, test automation becomes accessible to all. One of the standout features of Rapise v8.0 is its user-friendly interface, enabling users of all technical backgrounds to create and modify tests. Its visual keyword-driven framework, RVL, records actions and allows easy editing. Rapise's JavaScript-based engine offers seamless integration with open-source standards like Selenium and Appium, providing flexibility and extensibility for those who prefer to delve into the code. With a focus on maintainability and scalability, Rapise v8.0 introduces the highly anticipated new Framework mode, revolutionizing test case and test set management, parameterization, and seamless integration with Spira - Inflectra's quality engineering and project management platform. The new Framework mode in Rapise v8.0 offers a host of powerful features designed to enhance test automation efficiency and flexibility: Modules/Pages in Rapise v8.0 allow users to organize their test automation code into modular units with dedicated object repositories. This enables better code organization, isolation, and reuse, while parameters and return values enhance flexibility and reusability. Test Cases and Test Sets in Rapise v8.0's Framework mode gain their private object repositories, offering a dedicated space for organizing test-specific elements and allowing for quick assessment of test case execution outcomes and streamlining test set creation and management. Rapise v8.0's Framework mode introduces Configurations, a powerful feature for managing parameters that enables fine-tuning of the test behavior and facilitates comprehensive and customizable parameterization. Rapise v8.0 Framework mode eliminates the burden of manually loading different libraries for different technologies. Rapise will recognize and automatically load the required libraries as it detects the technology being used. "Rapise v8.0's new Framework mode has a transformative power to optimize test automation workflows and empower technical teams to achieve unparalleled efficiency and effectiveness in test automation. Automatic loading of the libraries will unlock the full potential of test automation in companies of all sizes, while its integrated Spira Dashboard will make the execution of tests simpler and more effective,” said Inflectra CEO Adam Sandman. Inflectra offers a suite of intuitive, turnkey enterprise solutions to manage the entire software lifecycle. Its industry-leading products for application test management, test automation, and lifecycle management help customers streamline their operations, allowing developers, testers and managers to allocate their time and resources to business-critical assignments. Among our most popular products are SpiraPlan, giving you the ability to synchronize what matters with agile program development, and Rapise, providing fast and easy test automation for everything—web, mobile, desktop, and APIs. Founded in 2006 and headquartered in the United States, Inflectra now has offices in more than ten countries, along with a global partner network that covers more than 5,000 customers worldwide. Contact Details Sara Reister +1 215-896-3243 inflectra@trustrelations.agency Company Website https://www.inflectra.com/

June 21, 2023 09:00 AM Eastern Daylight Time

FiscalNote (NYSE: NOTE) Reports 21% Year-On-Year Growth In Revenue In Q1 2023 and Expects Positive Adjusted EBITDA in Q4

Benzinga

By Jad Malaeb, Benzinga On May 10, 2023, FiscalNote Holdings Inc. (NYSE: NOTE) announced its financial results for the first quarter that ended on March 31, 2023. FiscalNote, a provider of global policy and market intelligence, reported a 21% increase in revenue to $31.5 million compared to the same period in the previous year. This result was consistent with the guidance range previously provided. FiscalNote's subscription revenue, which accounted for approximately 90% of its total revenue, grew 25% year-over-year, with 14% of that increase being organic. The company reported a gross profit of $22.6 million, representing a gross margin of 72%, while non-GAAP adjusted gross profit was $25.2 million, representing an 80% non-GAAP adjusted gross margin. The company had a GAAP net loss of $19.3 million and an adjusted EBITDA loss of $7.0 million with higher Q1 seasonal public company costs, which was consistent with its previous guidance. FiscalNote continued to demonstrate its leadership in delivering AI-enabled policy and market information which empowers organizations to mitigate risk and navigate businesses confidently in an increasingly complex global geopolitical, economic, and regulatory environment. The company's first quarter operational metrics showed an organic run-rate revenue increase of 9% to $124 million as of March 31, 2023, a 19% total growth year-over-year (YoY), and a 10% growth over the prior year on a proforma basis. Its Annual Recurring Revenue was approximately $119 million on March 31, 2023, representing a 19% total growth year-over-year and a 10% growth over the prior year on a proforma basis. FiscalNote’s financial outlook for the second quarter of 2023 foresees a GAAP revenue of $32 million to $34 million, representing 18% to 25% YoY growth, and an adjusted EBITDA loss of $4.5 million to $3.5 million for the quarter. The company has implemented efficiency programs that leverage its prior investments in technology and sales and marketing to optimize operations, enhance the company’s go-to-market strategy, and reduce costs, which are all expected to significantly benefit adjusted EBITDA starting in the second quarter. FiscalNote reiterated its full-year 2023 guidance, with a GAAP revenue of $136 million to $141 million – representing 20% to 24% year-over-year growth – and total run-rate revenue of $148 million to $155 million, representing growth of 17% to 22% over the prior year on a proforma basis. Additionally, FiscalNote expects to achieve approximately break-even adjusted EBITDA in the third quarter and positive adjusted EBITDA in the fourth quarter of 2023, marking an improvement of approximately 71% YoY. FiscalNote's CEO, Tim Hwang, said, "With each quarter, we are continuing to prove our model of building an enduring and resilient growth company with compounding subscription revenue growth, strong gross margins, and, over time, an impressive free cash flow model." The company's financial results demonstrate that FiscalNote is executing well on its plan to become a profitable enterprise SaaS technology provider, and it is confident that it will continue to maintain its leadership in the market. This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

June 21, 2023 09:00 AM Eastern Daylight Time

FDA Issues Warning Letter To iRhythm: An Opportunity For The Cardiac Monitoring Space And One Company In Particular?

Benzinga

By David Willey, Benzinga The Food and Drug Administration (FDA) has issued a warning to the heart monitoring company iRhythm (NASDAQ: IRTC), stating that its products include violations of FDA device and labeling standards. This highlights the prevalence of such issues in the sector – and opens up a space and creates opportunities for other companies in the remote monitoring and cardiac device market like Biotricity Inc. (NASDAQ: BTCY) which have maintained a robust, safety-first approach for their products. Biotricity is a medical technology company that has spent several years building out a complete cardiac product portfolio. Its goal is to provide best-in-class technology, and its innovative products have already helped deliver improvements to patients in the healthcare self-management sector. The company has consistently maintained an “overbuilding” approach to its products and the data and events they transmit, which ensures that its product limitations far exceed what is required. By positioning itself as a leader with its safety-first approach, Biotricity believes it is able to avoid problems that are affecting companies like iRhythm, an issue the company reports is indicative of problems in the larger healthcare system when it comes to companies that focus on selling drugs or clinical services. Some of iRhythm’s key violations as highlighted by the FDA include: End users were not told about the limit on the number of events (100 manual and 500 auto). Data including significant arrhythmias requiring physician notification were being held inaccessible since 2017. The FDA was not provided with device updates, including algorithm and hardware changes. Labeling and marketing claims stated the device can be used with high-risk patients, which is outside of the device’s use indications. Adverse events were not submitted to the FDA for patient injuries including deaths that may have been related to the other violations by iRhythm. This news has the potential to shake up the sector and open up a space in the remote monitoring industry. The market was worth $4.4 billion in 2022 and is set to grow at a compound annual growth rate (CAGR) of 18.5% over the next seven years. In collaboration with its affiliated cardiologist, Biotricity is focused on providing a premium product within the remote monitoring space. The company seems to be well-positioned to take advantage of the FDA’s announcement and the impact it will have on the remote monitoring sector. The company reached a record revenue run rate in April when it passed $13 million in annualized revenue. This extends its growth by more than 8% since March, with the growth being driven by sales of remote monitoring products plus subscription-based recurring revenues. The company anticipates its revenue growth to continue throughout 2023, with the CEO stating that the company was “starting to reach a critical mass with growing device sales.” Biotricity Brings AI To Cardiac Monitoring A recent article from the New England Journal of Medicine highlighted the important role of artificial intelligence (AI) in the future of healthcare. According to the article, AI will make it possible to quickly analyze large quantities of data, increasing efficiency and potentially providing new insights. Biotricity has already been working on AI products for several years, using AI technology to power its medical devices and pull deep data on its patients. Its flagship product, Bioflux®, connects physicians with 24/7 access to real-time data and has already recorded data on over 112 billion heartbeats. As a result, Bioflux has been able to identify 4,960 cardiac events in its more than 111,000 patients. This saved patients approximately $17,238 each and $85.5 million in total. There is a significant need for treatments and devices like Biotricity’s that help identify and prevent cardiovascular diseases (CVDs). Costs from treatment and premature death from CVDs are around $219 billion annually. CVDs claimed the lives of close to one million people in 2020, making it the leading cause of death in the United States. “Our algorithms for detection of cardiac anomalies are FDA-cleared, and for several years our team of dedicated AI software programmers are continually striving to push that envelope,” said Dr. Waqaas Al-Siddiq, Biotricity Founder and CEO. With a focus on improving patient outcomes through innovative solutions, Biotricity has been working with AI technology and its large datasets over the past few years to develop the next generation of diagnostics. As well as iRhythm, companies in the cardiac medical device sector include BioTelemetry Inc., Medtronic (NYSE: MDT) and Philips (NYSE: PHG). Read more about what Biotricity is doing here. This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

June 21, 2023 09:00 AM Eastern Daylight Time

Trust & Will to offer estate planning services through UBS Workplace Wealth Solutions

Trust & Will

Trust & Will, the leading digital estate planning and settlement platform in the US, today announced an agreement to provide discounted estate planning services to US-based employees of UBS’s corporate clients that participate in UBS Workplace Wealth Solutions ’ financial wellness program. Trust & Will provides an easy and secure way to create wills and trusts online, with the ability to customize legal estate planning documents that adhere to individual state and county guidelines. The platform uses bank-level encryption that protects customer data and complies with the highest security standards, including SOC 2 and HIPAA. Since launching in 2017, Trust & Will has helped nearly 500,000 families set up an estate plan to create a legacy. “The pandemic has drastically shifted our perspectives when it comes to work, and what we expect from our employers when it comes to providing comprehensive benefits, including education and resources for retirement, financial literacy, and equity planning,” said Cody Barbo, CEO and Founder of Trust & Will. “At Trust & Will, we pride ourselves on our award-winning company culture and are grateful for the opportunity to help build more rewarding workplaces across the country through UBS Financial Wellness.” According to recent UBS research, 68 percent of employees agree that companies have a responsibility to help them achieve high levels of financial wellness, especially the younger generations, who will soon represent more than half of the US workforce. Additionally, eight in 10 Gen Z and Millennial employees look to their companies for help with their overall financial well-being. “We look forward to helping employees of our corporate clients gain access to Trust & Will’s digital estate planning capabilities, which will provide them with greater control over their financial lives,” said Michael Barry, Head of UBS Workplace Wealth Solutions. “Many individuals do not have up-to-date wills or estate plans, and access to these tools will help them prepare for the future, shape their legacies, and provide a degree of support and clarity for their loved ones.” ABOUT TRUST & WILL Trust & Will is simplifying estate planning and settlement with attorney-approved, legally valid documents and processes designed to adhere to individual state guidelines. Since 2017, we’ve helped hundreds of thousands of Trust & Will members leave their legacy with an affordable way to create an estate plan or settle the estate of a loved one. Our platform uses bank-level encryption that protects customer data and complies with the highest security standards, including SOC 2 and HIPAA. Trust & Will is the official estate planning benefit provider for AARP members, along with several leading financial institutions, who all believe in our mission of helping every family leave their legacy. Trust & Will is an online service providing legal forms and information. We are not a law firm and we do not provide legal advice. ABOUT UBS WORKPLACE WEALTH SOLUTIONS UBS Workplace Wealth Solutions collaborates with corporate clients to deliver customized solutions across a range of programs for the workplace, including financial wellness, retirement and equity plans. We currently provide more than 10,000 employers and their two million employees in over 150 countries with access to financial knowledge, benefits programs that prepare them for retirement, and an integrated experience that combines the right mix of people and technology. We work side-by-side with our clients so that everyone feels rewarded at work and optimistic about realizing their long-term financial goals. To learn more about UBS Workplace Wealth Solutions, contact WorkplaceWealth@ubs.com or visit ubs.com/workplacesolutions. Contact Details Danielle Nuzzo +1 631-807-7772 danielle@trustandwill.com Company Website https://trustandwill.com

June 21, 2023 07:01 AM Eastern Daylight Time

NAVEX Study Finds Increasing Convergence of Risk and Compliance Priorities

NAVEX Global

NAVEX, the leader in integrated risk and compliance management software, today announced the publication of its 2023 State of Risk & Compliance Report. More than 1,300 risk and compliance (R&C) professionals from around the world were surveyed. Among the key findings of this study are a perceived decline in commitment to compliance among management teams, a persistent connection with information security (InfoSec) teams for the compliance function, and an increase in overall program maturity. The study also found notable differences across geographical responses. “This year’s findings demonstrate the importance of collaboration between the chief compliance officer (CCO) and chief information security officer (CISO) as the compliance risk landscape increasingly focuses on data privacy and information security concerns,” said Carrie Penman, NAVEX Chief Risk & Compliance Officer. “Risk and compliance professionals are continuing to work across departments to overcome the hurdles posed by the cyber-threat environment and the future of work.” Leadership’s commitment to risk and compliance The level of commitment demonstrated by management to the company’s compliance efforts fell by 8% from 2022 to 2023, while commitment in the face of conflicting interests and/or business objectives dropped by 9%. Three-quarters of respondents indicated that senior leaders encourage compliance within the organization, and nearly as many report seeing executives lead by example through commitment to the business’ compliance efforts. However, despite 70% saying senior leaders demonstrate adherence to compliance, only 47% said this persisted in the face of competing interests or objectives. Post-COVID hybrid work model Last year, 30% of survey respondents indicated their organizations anticipate most employees would return to in-office working conditions with an additional 56% predicting a hybrid scenario; with a fairly even mix of in-office and remote employees. Also last year, 62% of respondents said flexible, work-from-home models had a positive impact on workplace culture. This year, 93% of respondents said their organization is embracing a hybrid work model, if not fully remote, and nearly three-quarters (73%) say it has a somewhat or very positive effect on company ethos. It is well known that positive corporate cultures help drive better business outcomes. This dynamic is critically important as it relates to a remote workforce, who are typically under less direct supervision. For example, remote work makes observing policy and code of conduct violations or other undesired behaviors more challenging and it presents more IT security risks. Interdependence of compliance, data privacy, and IT/information security N early one-third (30% in 2023 vs. 22% in 2022) of respondents said their organization experienced a data privacy/cybersecurity breach in the past three years. Considering this real-world challenge compliance professionals are facing, cybersecurity (60%) and data privacy (57%) are two of the three most chosen topics respondents said their organization will train on in the next two-to-three years. Europe lags the US in focus on non-retaliation Despite regulatory pressures from the EU Whistleblower Directive, European respondents relegated whistleblowing, non-retaliation and related training as a low priority compared to the US. In the US, 66% of respondents said their organization planned ethics and code of conduct training in the next two-to-three years. However, only 45% of respondents in Germany and 38% in France said the same. This training is likely to include material to educate recipients about a non-retaliation policy. Experienced compliance professionals know that a strong non-retaliation policy is necessary for a reporting program to be effective. More than three-fifth of all respondents (68%) indicated that reporting, retaliation, and whistleblowing were either a “very important” or “absolutely essential” compliance issue for their organization, with the following distribution in select countries: 71% (US), 66% (UK), 60% (France), 59% (Germany). In the US, 61% of respondents indicated that there is a non-retaliation policy in place at their organization; this drops to 41% in Germany, followed by the UK at 36%, and France with only 27%. More respondents indicated that their organizations have a data privacy policy included in their ESG program (54%) than a non-retaliation policy as a part of their confidential reporting and investigatory program (51%). Surprisingly, the gap is especially wide in Europe, illustrating an important inconsistency between the intent of the EU Whistleblower Directive and the focus of the responding organizations. Access to and use of data A substantial majority of respondents (69%) said their access to sources of data to monitor and/or test policies, controls, and transactions, was either “sufficient” or “very sufficient.” Nearly seven out of ten respondents feel they have “sufficient” or “very sufficient” access to the data their programs need. It is notable that far fewer indicate they have a purpose-built solution to administer various program aspects (23-34%) such as incident management or policy management solutions. Depending on the program element, between 12% and 28% are still using a paper-based management method. This approach makes it difficult for programs to efficiently manage, analyze, and leverage the operational data they are bringing in. Program maturity and reporting structure Today’s stringent regulatory environment, combined with societal expectations for greater transparency, require more compliance rigor than ever before. Compared to 2022, a significantly greater share of respondents (53% in 2023 vs. 38% in 2022) described their programs as managing or optimizing (on the Ethics and Compliance Initiative HQP maturity levels of underdeveloped, defining, adapting, managing and optimizing). Interestingly, program maturity seems to have little impact on where inside the organization the compliance function reports. Among all respondents, a similar number of respondents (22%) reported that compliance is independent and reports to executive leadership. “Effective programs, ones with cross-functional collaboration, executive and manager buy-in, strong policies and training, robust internal whistleblowing/non-retaliation mechanisms and vigilant third-party management, are best poised to navigate the ever-changing regulatory landscape while fostering a culture of ethics and compliance. Even for the most mature programs, the task of fostering those dynamics will always be one of continuous improvement,” added Penman. To learn more, download the full report here or read the blog here. Register for The State of Risk & Compliance in 2023 webinar here. ### About 2023 State of Risk & Compliance Report The benchmark research was conducted online by The Harris Poll on behalf of NAVEX among 1,315 adults, who are non-academic professionals (management/non-management or higher) and knowledgeable about their organization’s risk and compliance program in the United States (n=738), United Kingdom (n=177), France (n=157), Germany (n=151), Canada (n=50), and other countries (n=42). The survey was conducted between January 30 – March 10, 2022. About NAVEX NAVEX is trusted by thousands of customers worldwide to help them achieve the business outcomes that matter most. As the global leader in integrated risk and compliance management software and services, we deliver our solutions through the NAVEX One platform, the industry’s most comprehensive governance, risk, and compliance (GRC) information system. Contact Details Anita Lo +44 7778 754858 anita.lo@navex.com Company Website https://www.navex.com

June 21, 2023 12:00 AM Eastern Daylight Time

Minuteman Press Franchise in Huntersville, NC Has Grand Opening for Brand New Location

Minuteman Press International Inc

Neha Katrodia is the owner of the brand new Minuteman Press design, marketing, and printing franchise located at 9606 Sherrill Estates Rd., Suite A, Huntersville, NC 28078. After opening their doors in March of 2023, Minuteman Press in Huntersville held their official grand opening and ribbon-cutting ceremony on Friday, June 2, 2023. The event was hosted by the Lake Norman Chamber of Commerce and was attended by Huntersville Commissioner Dan Boone. Neha shares, “The Huntersville community has been very welcoming and interested in learning more about our business. I'm so thankful to everyone who came to support us during the grand opening and showed interest in growing together.” She continues, “Owning my own business means taking on my father's path to becoming an entrepreneur. Most importantly, I feel a sense of personal fulfillment and I look forward to seeing this new venture grow and succeed while helping other local businesses with all of their printing and promotional needs.” Joining Neha in the business are two key staff members: Denis Vargas, graphic designer/production; as well as Neha’s husband Mehul Katrodia, marketing agent. While Denis provides clients with custom creative designs and a sharp eye for details, Mehul manages the marketing side including Google and social media accounts. Neha, meanwhile, has already jumped into several networking groups to become active in the community, including the Lake Norman Chamber of Commerce as well as the Huntersville BNI group. She says, “I feel it’s important to get out there and engage with clients in person and also market our business online. Once clients come to us, we enjoy working with them to bring their visions to life and delivery high quality products and service. Our staff is ready and willing to welcome clients to Minuteman Press in Huntersville with open arms.” Prior to buying the business, Neha always had wanted to follow in her father’s footsteps and become her own boss. She explains, “I have a healthcare and medical billing background; however, I grew up in the business environment. My father has been a businessman from my early childhood years and has owned various businesses from then to now. I also helped him run some of them due to the language barrier he had at times.” Neha further shares why she chose to own a Minuteman Press franchise, stating: “The continuous local support that Minuteman Press offers is amazing; The B2B hours of operation allow me to balance my business and personal lives; Minuteman Press allows me to follow my passion for creating something so unique with every project or job.” She adds, “The training program was extremely informative and allowed me to feel confident in front of clients. Now, the local support to lean on here in my region has been so helpful with advice and guidance on unique projects. We also use the Minuteman Press FLEX software made available to us as a key marketing tool for growth.” Following the successful grand opening, Neha is excited for the future of her new business. She concludes, “At Minuteman Press, we love working with other local businesses and organizations. I look forward to supporting them with our personalized products and services as we are all in this together.” Minuteman Press in Huntersville is located at 9606 Sherrill Estates Rd., Suite A, Huntersville, NC 28078. For more information, call 704-594-8699 or visit their website: https://minuteman.com/us/locations/nc/huntersville/ Learn more about #1 rated Minuteman Press franchise opportunities and read Minuteman Press franchise reviews at https://minutemanpressfranchise.com Contact Details Minuteman Press International Chris Biscuiti +1 631-249-1370 cbiscuiti@mpihq.com Company Website https://minutemanpressfranchise.com

June 20, 2023 10:00 AM Eastern Daylight Time

Image

DfT Minister Visits Prologis UK’s Flagship Site to See How Mobilityways Technology can Decarbonise Workers’ Commutes

Mobilityways

The Minister of State for Decarbonisation and Technology Rt Hon Jesse Norman MP visited Daventry Intermodal Rail Freight Terminal (DIRFT) on Thursday 15 June. The visit, jointly hosted by Prologis UK and Mobilityways, provided the minister with the opportunity to better understand how workers at Prologis RFI DIRFT are using technology to share commuting data, thereby optimising public transport route planning and car sharing possibilities. DIRFT is recognised as the most successful intermodal (rail/road) logistics park in the UK - twelve freight trains a day stop at the site, a number expected to grow as part of Prologis’s quest to reduce the site’s carbon footprint further. As part of its focus on sustainability, Prologis is working with commuter emissions solutions provider Mobilityways across its logistics parks nationwide. Mobilityways provides its car sharing platform Liftshare and is working with six of their sites, including DIRFT, to analyse the commuting habits and sustainable travel options of the staff of its most valued customers. Decarbonisation and Technology Minister Jesse Norman said: “The Department wants to support commuters to make use of lower carbon ways of commuting. It was great to be in Rugby to see the work Mobilityways and Zeelo are doing to help employees at the Daventry Intermodal Rail Freight Terminal make their commutes cleaner, helping companies based at the site reach a wider pool of talent.” David Mellor, Director, Project Management at Prologis UK: “We see the sharing of commute data with our customer at DIRFT as a great way to add value and support their operations. These companies are all major employers seeking to reduce their carbon emissions. Sustainability is at the forefront of our business - we have already reduced the embedded carbon in our UK warehouses by 26 per cent since 2008, and the next logical step is to look at getting our customers’ staff to work more sustainably by offering car sharing arrangements and green transport alternatives.” The Department for Transport is working closely with innovators like Mobilityways, Prologis and key trade bodies to help offer training, advice and technology to remove barriers to decarbonising employee commutes as well as across the transport and logistics sector as whole. The Government’s growing focus on employee commute emissions reduction led to the subject being featured in the Department for Transport’s Commute Zero policy detailed in its Decarbonising Transport Plan which was first published in July 2021 and recently updated. Basil Choudhry, Commercial Director at Mobilityways: “The Decarbonising Transport Plan makes it clear that the commute to the office is the least carbon efficient journey we ever make. It contributes 1.8 billion kg of C02e annually amounting to five per cent of total UK emissions. “Part of the problem is that 90 per cent of us travel to work alone when Mobilityways’s analysis suggests that up to 40 per cent of us could use public transport to get to work. A further 40 per cent could cycle and an estimated 10 million commuting Brits could share a lift into work.” ends The image taken outside The Hub, Centre for Logistics Training & Education at DIRFT Includes, from Left to Right: Sam Hunt – Senior Account Manager - Mobilityways Limited, Dave Mellor – Director of Space Development and Management, UK - Prologis Ali Clabburn – Founder & CEO - Mobilityways Lewis Evans – Customer Success Manager - Royal Mail Ben Bhattal -Business Development Director - Royal Mail Fiona Hamilton – Head of Public Affairs, Royal Mail Rt Hon Jessa Norman, Minister of Decarbonisation & Technology - Department for Transport Liz Allister – Real Estate and Customer Experience Director - Prologis John Slingsby – CFO - Zeelo Steve haddock – Real Estate & Customer Experience Director – Prologis Sandy Bhamra – DIRFT Park Manager - Prologis About Mobilityways: Mobilityways is a climate tech firm on a mission to make zero carbon commuting a reality. It supports employers in meeting their Net Zero goals with its suite of climate tech tools. These tools enable companies to measure, reduce and report their commuter emissions, providing full visibility of commuting challenges and identifying sustainable travel alternatives for employees. Mobilityways already works with over 700 companies. It also operates a highly successful car sharing platform called Liftshare which is now the UK’s leading car share provider. Liftshare has been running for 25 years and was the original name of the group before it was renamed Mobilityways at the start of this year. For further information about Mobilityways, please contact: Jack Goddard, Senior Marketing Executive at Mobilityways. Email: Jack.Goddard@mobilityways.com Contact Details Agility PR Miles Clayton +44 7799 063398 miles@agilitypr.co.uk

June 20, 2023 08:47 AM Eastern Daylight Time

Image

“VASP Licensing Regime & Industry Best Practices” exclusive event hosted by ChainUp & Alibaba Cloud - Hong Kong

ChainUp

Hong Kong – 16 th June 2023 – ChainUp a global blockchain technology service provider & Alibaba Cloud hosted an exclusive event on latest Virtual Asset Service Provider (VASP) Licensing Regime & industry best practices in Hong Kong. Amidst the growing significance of regulatory compliance within the blockchain and cryptocurrency industry, the event offered attendees valuable and comprehensive insights into effectively tackling the challenges and capitalizing on the opportunities encountered by VASPs operating not only in Hong Kong but also in global markets. The event took place on 16 th June 2023 at Time Square - Causeway Bay, Hong Kong. Industry experts, leaders and regulatory authorities discussed key topics and shared their insights to navigate the evolving landscape of virtual asset services. Mr. Michael Gao, ChainUp – HK CEO & Head of Sales (Global) spoke about “The Technological Bridge to Regulated Virtual Assets Exchange in Hong Kong”. He highlighted on the recent Hong Kong Securities and Futures Commission’s new licensing regime which came into effect from 1 st June 2023 and requirements for centralized virtual asset trading platforms (VA trading platforms) to trade non-security tokens. He said “In traditional finance, banks use KYC (Know Your Customer) to verify the identity of customers. But in blockchain network we need to understand whether a particular token has any risk. Hence KYT (Know Your Transaction) is used to monitor and analyse digital asset transactions to identify potential risks and comply with regulations. We see there's a strong demand on this and we help our customers by integrating the required compliant solutions into the exchanges built” The event covered various aspects of the VASP Licensing Regime, including: Regulatory framework overview in Hong Kong Key requirements for obtaining a VASP license Best practices for compliance, security and risk management ChainUp, a global provider of comprehensive blockchain technology solutions help customers build efficient and compliant digital asset solutions that align with the latest industry standards. With ChainUp’s extensive suite of services, empowers businesses to navigate the complexities of digital asset landscape and build robust solutions. Aligned with latest licensing regime of Hong Kong, the implementation of KYT/AML solutions becomes imperative for digital asset transactions. ChainUp's product "ChainEyes KYT" focusing on blockchain risk control and compliance services offers a comprehensive solution to address these regulatory requirements effectively. About ChainUp Group Founded in 2017, ChainUp is a leading end-to-end blockchain technology solutions provider covering infrastructure development and ecosystem support. Built on the mission to empower businesses through blockchain technology, ChainUp’s innovative and all-around compliant solutions include digital asset exchange systems, NFT trading systems, wallet solutions, liquidity solutions, and digital assets custody and management. Headquartered in Singapore and with offices around the world, the company has served more than 1,000 clients in 30 countries, reaching over 60 million end-users. For more information, please visit: www.chainup.com. Contact Details ChainUp Media Team pressrelease@chainup.com Company Website https://www.chainup.com/

June 19, 2023 10:38 PM Eastern Daylight Time

Image

1 ... 250 251 252 253 254 ... 620